OverviewChartNewsTraderScreen

Soc. Generale Discount Zert SQ 27.../  DE000SW20S73  /

EUWAX
2024-05-31  9:58:24 AM Chg.-0.03 Bid10:00:36 PM Ask10:00:36 PM Underlying Strike price Expiration date Option type
31.68EUR -0.09% -
Bid Size: -		 -
Ask Size: -		 Block Inc - USD 2024-09-27 Call
GlobeNewswire 7:30 AM Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
GlobeNewswire 7:30 AM Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...
GlobeNewswire 6:51 AM Flash News: OKX to Support Mina Protocol's Upgrade
GlobeNewswire 6:41 AM Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
GlobeNewswire 6:02 AM NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
GlobeNewswire 6:00 AM IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
GlobeNewswire 6:00 AM BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 5:01 AM AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
GlobeNewswire 5:00 AM AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Road...
GlobeNewswire 4:59 AM AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire 4:13 AM Flash News: OKX Launches 100% Fee Rebate Campaign
GlobeNewswire 2:38 AM Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire 2:23 AM Mesoblast Corporate Presentation at Investor Conference
GlobeNewswire 2:00 AM HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 1:00 AM Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire 12:43 AM Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
GlobeNewswire 06-02 Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire 06-02 Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire 06-02 KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire 06-02 Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
GlobeNewswire 06-02 Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire 06-02 Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire 06-02 ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire 06-02 Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire 06-02 BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...